Development of solid lipid nanoparticles for sustained release of anticancer agents
A brief introduction to solid lipid nanoparticles (SLN) is provided and the reasoning behind the use of SLN over other colloidal carriers, such as emulsions and liposomes, are discussed. SLN has many advantageous such as controlled drug release, non-biotoxicity of the carrier, increased bioavailabil...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Greenwich
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.732822 |